BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 20947818)

  • 1. Annexin A5 therapy attenuates vascular inflammation and remodeling and improves endothelial function in mice.
    Ewing MM; de Vries MR; Nordzell M; Pettersson K; de Boer HC; van Zonneveld AJ; Frostegård J; Jukema JW; Quax PH
    Arterioscler Thromb Vasc Biol; 2011 Jan; 31(1):95-101. PubMed ID: 20947818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical HDL administration reduces vein graft atherosclerosis in apo E deficient mice.
    Feng Y; Gordts SC; Chen F; Hu Y; Van Craeyveld E; Jacobs F; Carlier V; Feng Y; Zhang Z; Xu Q; Ni Y; De Geest B
    Atherosclerosis; 2011 Feb; 214(2):271-8. PubMed ID: 20943224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of endothelial cell-derived angptl2 in vascular inflammation leading to endothelial dysfunction and atherosclerosis progression.
    Horio E; Kadomatsu T; Miyata K; Arai Y; Hosokawa K; Doi Y; Ninomiya T; Horiguchi H; Endo M; Tabata M; Tazume H; Tian Z; Takahashi O; Terada K; Takeya M; Hao H; Hirose N; Minami T; Suda T; Kiyohara Y; Ogawa H; Kaikita K; Oike Y
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):790-800. PubMed ID: 24526691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Annexin A5 prevents post-interventional accelerated atherosclerosis development in a dose-dependent fashion in mice.
    Ewing MM; Karper JC; Sampietro ML; de Vries MR; Pettersson K; Jukema JW; Quax PH
    Atherosclerosis; 2012 Apr; 221(2):333-40. PubMed ID: 22341596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice.
    Sukhanov S; Higashi Y; Shai SY; Vaughn C; Mohler J; Li Y; Song YH; Titterington J; Delafontaine P
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2684-90. PubMed ID: 17916769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heat shock protein 90 inhibitors attenuate inflammatory responses in atherosclerosis.
    Madrigal-Matute J; López-Franco O; Blanco-Colio LM; Muñoz-García B; Ramos-Mozo P; Ortega L; Egido J; Martín-Ventura JL
    Cardiovasc Res; 2010 May; 86(2):330-7. PubMed ID: 20154064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral administration of tetrahydrobiopterin slows the progression of atherosclerosis in apolipoprotein E-knockout mice.
    Hattori Y; Hattori S; Wang X; Satoh H; Nakanishi N; Kasai K
    Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):865-70. PubMed ID: 17272747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Major contribution of the P2Y₁receptor in purinergic regulation of TNFα-induced vascular inflammation.
    Zerr M; Hechler B; Freund M; Magnenat S; Lanois I; Cazenave JP; Léon C; Gachet C
    Circulation; 2011 May; 123(21):2404-13. PubMed ID: 21576651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of endothelial function by systemic transfusion of vascular progenitor cells.
    Wassmann S; Werner N; Czech T; Nickenig G
    Circ Res; 2006 Oct; 99(8):e74-83. PubMed ID: 16990568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that niacin inhibits acute vascular inflammation and improves endothelial dysfunction independent of changes in plasma lipids.
    Wu BJ; Yan L; Charlton F; Witting P; Barter PJ; Rye KA
    Arterioscler Thromb Vasc Biol; 2010 May; 30(5):968-75. PubMed ID: 20167660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MDOC and atorvastatin have potential antiinflammatory effects in vascular endothelium of apoE-/- mouse model of atherosclerosis.
    Nachtigal P; Pospisilova N; Pospechova K; Jamborova G; Kopecky M; Jaynes R; Briestensky J; Santar I; Smahelova A; Solichova D; Zdansky P; Semecky V
    Life Sci; 2006 Mar; 78(17):1983-9. PubMed ID: 16305803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. n-6 and n-3 Fatty acids and atherosclerosis: ratios or amounts?
    Deckelbaum RJ
    Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2325-6. PubMed ID: 21084701
    [No Abstract]   [Full Text] [Related]  

  • 13. L-4F, an apolipoprotein A-1 mimetic, dramatically improves vasodilation in hypercholesterolemia and sickle cell disease.
    Ou J; Ou Z; Jones DW; Holzhauer S; Hatoum OA; Ackerman AW; Weihrauch DW; Gutterman DD; Guice K; Oldham KT; Hillery CA; Pritchard KA
    Circulation; 2003 May; 107(18):2337-41. PubMed ID: 12732610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD137 (4-1BB) deficiency reduces atherosclerosis in hyperlipidemic mice.
    Jeon HJ; Choi JH; Jung IH; Park JG; Lee MR; Lee MN; Kim B; Yoo JY; Jeong SJ; Kim DY; Park JE; Park HY; Kwack K; Choi BK; Kwon BS; Oh GT
    Circulation; 2010 Mar; 121(9):1124-33. PubMed ID: 20176988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liraglutide treatment improves endothelial function in the Ldlr-/- mouse model of atherosclerosis and affects genes involved in vascular remodelling and inflammation.
    Bjørnholm KD; Skovsted GF; Mitgaard-Thomsen A; Rakipovski G; Tveden-Nyborg P; Lykkesfeldt J; Povlsen GK
    Basic Clin Pharmacol Toxicol; 2021 Jan; 128(1):103-114. PubMed ID: 32896073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. c-Jun N-terminal kinase 2 deficiency protects against hypercholesterolemia-induced endothelial dysfunction and oxidative stress.
    Osto E; Matter CM; Kouroedov A; Malinski T; Bachschmid M; Camici GG; Kilic U; Stallmach T; Boren J; Iliceto S; Lüscher TF; Cosentino F
    Circulation; 2008 Nov; 118(20):2073-80. PubMed ID: 18955669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of LOX-1 reduces atherogenesis in LDLR knockout mice fed high cholesterol diet.
    Mehta JL; Sanada N; Hu CP; Chen J; Dandapat A; Sugawara F; Satoh H; Inoue K; Kawase Y; Jishage K; Suzuki H; Takeya M; Schnackenberg L; Beger R; Hermonat PL; Thomas M; Sawamura T
    Circ Res; 2007 Jun; 100(11):1634-42. PubMed ID: 17478727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activating SIRT1: a new strategy to prevent atherosclerosis?
    Brandes RP
    Cardiovasc Res; 2008 Nov; 80(2):163-4. PubMed ID: 18784217
    [No Abstract]   [Full Text] [Related]  

  • 19. Regression of atherosclerosis by amlodipine via anti-inflammatory and anti-oxidative stress actions.
    Yoshii T; Iwai M; Li Z; Chen R; Ide A; Fukunaga S; Oshita A; Mogi M; Higaki J; Horiuchi M
    Hypertens Res; 2006 Jun; 29(6):457-66. PubMed ID: 16940709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenously decreasing tissue n-6/n-3 fatty acid ratio reduces atherosclerotic lesions in apolipoprotein E-deficient mice by inhibiting systemic and vascular inflammation.
    Wan JB; Huang LL; Rong R; Tan R; Wang J; Kang JX
    Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2487-94. PubMed ID: 20705919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.